{
  "id": "cluster_47_doc3",
  "content": "Internal memo regarding policy XG229 revisions effective March 1, 2024: Expanded coverage for neuromodulation devices in patients under 60 with failed conventional therapies. Flags cases meeting new criteria - cross-reference with appeals in processing queue, including account 487632WQ (Wildermuth).",
  "metadata": {
    "format": "insurance_memo"
  }
}